Literature DB >> 6185587

Transformation of murine LMTK- cells with purified HLA class I genes. I. Modification of conformation of murine beta 2-microglobulin upon its association with HLA heavy chains.

F A Lemonnier, P P Le Bouteiller, B Malissen, P Golstein, M Malissen, Z Mishal, D H Caillol, B R Jordan, F M Kourilsky.   

Abstract

Murine LMTK- cells were unexpectedly found to cross-react with a murine anti-human beta 2-microglobulin (beta 2-m)monoclonal antibody (m.Ab) after transformation with cosmid clones containing different purified HLA class I genes. The same cross-reactivity was observed with CTP 34 B4 (murine x human) somatic hybrid cells, which express class I molecules constituted of human HLA heavy chains and murine beta 2-m. Inhibition studies of the complement-dependent cytolysis mediated by the cross-reacting m.Ab indicated that isolated murine beta 2-m does not express the cross-reacting determinant, suggesting that its expression by the transformed cells reflects conformational modification of murine beta 2-m upon its association with HLA heavy chains. These results illustrate one of the possible post-translational mechanisms through which the antigenicity of a polypeptide chain can be modified. They might provide a serologic marker of the third domain of HLA class I heavy chains. Finally, because quantitative differences of reactivity with the anti-human beta 2-m m.Ab were observed, depending on the HLA class I genes used for transformation, these results individualize two families of HLA class I heavy chains responsible for different conformational modifications of murine beta 2-m.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6185587

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Expression of an HLA-Bw6-related specificity by the HLA-Cw3 molecule.

Authors:  C Layet; T Delovitch; P Ferrier; D H Caillol; B R Jordan; F A Lemonnier
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

2.  Serological expression after sequential double transfection with purified HLA-A11 gene of mouse fibroblasts carrying human beta-2 microglobulin.

Authors:  P Paul; V Lepage; B Sayagh; J J Metzger; M Pla; L Boumsell; C Douay; D Cohen; J Colombani; J Dausset
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

3.  Self-tolerance to HLA focuses the response of immunized HLA-transgenic mice on production of antibody to precise polymorphic HLA alloantigens.

Authors:  G J Hämmerling; J W Chamberlain; O Dill; S Y Yang; B Dupont; R Khan; R Chua; S M Weissman; U Hämmerling
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

4.  Transformation of LMTK- cells with purified HLA class I genes. II. Serologic characterization of HLA-A3 and CW3 molecules.

Authors:  F A Lemonnier; P C Dubreuil; C Layet; M Malissen; D Bourel; P Mercier; B K Jakobsen; D H Caillol; A Svejgaard; F M Kourilsky; B R Jordan
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

5.  Transformation of murine LMTK- cells with purified HLA class I genes. III. Human HLA class I antigens coded by hybrid genes constructed in vitro indicate association of serologic reactivities with the first two domains of the molecule.

Authors:  B R Jordan; F A Lemonnier; D H Caillol; J Trucy
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

6.  Recognition of HLA-A2 and -B7 antigens by cloned cytotoxic T lymphocytes after gene transfer into human and monkey, but not mouse, cells.

Authors:  J A Barbosa; S J Mentzer; G Minowada; J L Strominger; S J Burakoff; P A Biro
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

7.  The association of H-2Ld with human beta-2 microglobulin induces localized conformational changes in the alpha-1 and -2 superdomain.

Authors:  M C Nieto; E S Song; D McKinney; M McMillan; R S Goodenow
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

8.  Recognition by xenogeneic cytotoxic T lymphocytes of cells expressing HLA-A2 or HLA-B7 after DNA-mediated gene transfer.

Authors:  A Herman; P Parham; S M Weissman; V H Engelhard
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

9.  H-2-specific antibodies induced by injection of syngeneic leukemia cells.

Authors:  W Schmidt
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

10.  Elimination or rescue of cells in culture by specifically targeted liposomes containing methotrexate or formyl-tetrahydrofolate.

Authors:  P Machy; L D Leserman
Journal:  EMBO J       Date:  1984-09       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.